The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
Open accessAbstract
The presence of hepatitis C virus (HCV) RNA-containing particles in the low-density fractions of plasma has been associated with high infectivity. However, the nature of circulating HCV particles and their association with immunoglobulins or lipoproteins as well as the characterization of cell entry have all been subject to conflicting reports. For a better analysis of HCV RNA-containing particles, we quantified HCV RNA in the low-density fractions of plasma corresponding to the very-low-density lipoprotein (VLDL), intermediate-density lipoprotein, and low-density lipoprotein (LDL) fractions from untreated chronically HCV-infected patients. HCV RNA was always found in at least one of these fractions and represented 8 to 95% of the total plasma HCV RNA. Surprisingly, immunoglobulins G and M were also found in the low-density fractions and could be used to purify the HCV RNA-containing particles (lipo-viro-particles [LVP]). Purified LVP were rich in triglycerides; contained at least apolipoprotein B, HCV RNA, and core protein; and appeared as large spherical particles with a diameter of more than 100 nm and with internal structures. Delipidation of these particles resulted in capsid-like structures recognized by anti-HCV core protein antibody. Purified LVP efficiently bind and enter hepatocyte cell lines, while serum or whole-density fractions do not. Binding of these particles was competed out by VLDL and LDL from noninfected donors and was blocked by anti-apolipoprotein B and E antibodies, whereas upregulation of the LDL receptor increased their internalization. These results suggest that the infectivity of LVP is mediated by endogenous proteins rather than by viral components providing a mechanism of escape from the humoral immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1200 · Cited by 658
Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J., & Purcell, R. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15394 · Cited by 603
Recycling receptors: the round-trip itinerary of migrant membrane proteins
Brown, M. S., Anderson, R. G. W., & Goldstein, J. L. (1983) · Cell · doi:10.1016/0092-8674(83)90052-1 · Cited by 587
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes
Hijikata, M., Shimizu, Y. K., Kato, H., Iwamoto, A., Shih, J. W., Alter, H. J., Purcell, R. H., & Yoshikura, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1953-1958.1993 · Cited by 373
Association of hepatitis C virus in human sera with ?-lipoprotein
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.-H., K�chel, H. G., & Uy, A. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00198849 · Cited by 366
Schneider, W. J., Beisiegel, U., Goldstein, J. L., & Brown, M. S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34975-5 · Cited by 279
Sensitization to Fas-Mediated Apoptosis by Hepatitis C Virus Core Protein
Ruggieri, A., Harada, T., Matsuura, Y., & Miyamura, T. (1997) · Virology · doi:10.1006/viro.1996.8420 · Cited by 244
THOMSSEN, R., Bonk, S., & Thiele, A. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00191948 · Cited by 234
Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N., & Stapleton, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10055-10062.2000 · Cited by 222
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44181-0 · Cited by 220 · cited 8×
“Synthesis and secretion of these particles occur in hepatocytes in the form of very-low-density lipoprotein (VLDL) (density of 1.0063 g/ml) with apolipoproteins B and E (ApoB and ApoE, respectively).”
BackgroundInfluentialIntroduction:Structure and metabolism of plasma lipoproteins.
Havel, J. (1995) · Medical Entomology and Zoology · Cited by 179
Sabile, A., Perlemuter, G., Bono, F., Kohara, K., Demaugre, F., Kohara, M., Matsuura, Y., Miyamura, T., Bréchot, C., & Barba, G. (1999) · Hepatology · doi:10.1002/hep.510300429 · Cited by 173
Hepatitis C virus: Buoyant density if the factor VIII‐derived isolate in sucrose
Bradley, D., McCaustland, K., Krawczynski, K., Spelbring, J., Humphey, C., & Cook, E. H. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890340315 · Cited by 165
The low density lipoprotein receptor
Schneider, W. J. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(89)90023-3 · Cited by 159
Duvet, S., Cocquerel, L., Pillez, A., Cacan, R., Verbert, A., Moradpour, D., Wychowski, C., & Dubuisson, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32088 · Cited by 147
Milne, R. W., Théolis, R., Maurice, R., Pease, R. J., WEECH, P. K., Rassart, É., Fruchart, J., Scott, J., & Marcel, Y. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47176-7 · Cited by 128
Cell Fusion Activity of Hepatitis C Virus Envelope Proteins
Takikawa, S., Ishii, K., Aizaki, H., Suzuki, T., Asakura, H., Matsuura, Y., & Miyamura, T. (2000) · Journal of Virology · doi:10.1128/.74.11.5066-5074.2000 · Cited by 128
A Guidebook to Lipoprotein Technique
MILLS, G. L., Lane, P. A., & WEECH, P. K. (1984) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(08)x7024-x · Cited by 118
Quantitation of HCV RNA using real-time PCR and fluorimetry
Komurian-Pradel, F., Paranhos‐Baccalà, G., Sodoyer, M., Chevallier, P., Mandrand, B., Lotteau, V., & André, P. (2001) · Journal of Virological Methods · doi:10.1016/s0166-0934(01)00300-7 · Cited by 102
Self-citationPatel, A. H., Wood, J., Pénin, F., Dubuisson, J., & McKeating, J. A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-12-2873 · Cited by 93
Assembly of Very Low Density Lipoprotein: A Two-Step Process of Apolipoprotein B Core Lipidation
Rustaeus, S., Lindberg, K., Stillemark-Billton, P., Claesson, C., Asp, L., Larsson, T. P., Borén, J., & Olofsson, S. (1999) · Journal of Nutrition · doi:10.1093/jn/129.2.463s · Cited by 87
Goldstein, J. L., Sobhani, M. K., Faust, J. R., & Brown, M. S. (1976) · Cell · doi:10.1016/0092-8674(76)90110-0 · Cited by 79
Shelness, G. S., Ingram, M. F., Huang, X. F., & DeLozier, J. A. (1999) · Journal of Nutrition · doi:10.1093/jn/129.2.456s · Cited by 72
Lodish, H. F., & Porter, M. B. (1980) · Cell · doi:10.1016/0092-8674(80)90397-9 · Cited by 71
Monazahian, M., Kippenberger, S., Müller, A., Seitz, H., Böhme, I., Grethe, S., & THOMSSEN, R. (2000) · Medical Microbiology and Immunology · doi:10.1007/s004300000032 · Cited by 67
Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection
Choo, S. H., So, H., Cho, J.-M., & Ryu, W. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2337 · Cited by 62
The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin
Yao, X., Wainberg, M. A., Richard, M., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2636 · Cited by 6
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., & McKeating, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832180100 · Cited by 795
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Heaton, N. S., & Randall, G. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.006 · Cited by 705
Metadata
- Authors
- André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2002-07-15
- Volume
- 76
- Issue
- 14
- Pages
- 6919-6928
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2036306822
- Cited by
- 690
- References
- 32
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.